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Background: Schwannomas are slow-growing typically encapsulated tumors composed of differentiated Schwann
cells, the primary class of peripheral glial cells. Complete excision is the treatment of choice for orbital
schwannomas that cause pain, disfigurement, diplopia, or optic neuropathy. The presence of multiple schwannomas
in a single patient suggests possible association with neurofibromatosis type 2 (NF2) or schwannomatosis.
Case presentation: We present 2 patients who experienced recurrent orbital schwannoma without evidence for
neurofibromatosis. The recurrence in one patient, a 59-year old man, occurred 6 years after complete excision of
the initial tumor. This recurrence consisted of 2 independent tumors in the same orbit. The recurrence in the
second patient, a 5 year-old girl, occurred multiple times within days to weeks of partial excisions until eventually
a complete excision was performed.
Conclusion: The clinical history, histopathologic features and particularly the intraoperative findings suggest that
the 59 year old man suffers from orbital schwannomatosis, while the rapid recurrence in the second patient
correlated with the cellular features of her plexiform schwannoma. Hence, the recurrence in each patient is linked
to a different etiology, with implications for treatment and patient counseling given the difficulty in treating orbital
schwannomatosis. To our knowledge, this is the first description of isolated orbital schwannomatosis.Background
Schwannomas are slow-growing typically encapsulated
tumors composed of differentiated Schwann cells, the
primary class of peripheral glial cells. They can occur in
any location, but occur infrequently in the orbit, repre-
senting only 1% of orbital tumors [1,2]. Schwannomas
are most common in the 20- to 50-year-old age group,
but may occur at any age. No frequency variation
according to sex has been identified [3]. A review of the
literature suggests that in the post-CT era, very few
cases of pediatric schwannoma have been reported [4,5].
Complete excision is the treatment of choice for orbital
schwannomas that cause pain, disfigurement, diplopia, or
optic neuropathy [6-8]. Histologically, schwannomas are
usually encapsulated with alternating cellular schwann-
cell rich Antoni-A areas and less cellular and myxoid* Correspondence: akahana@med.umich.edu
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reproduction in any medium, provided the orAntoni-B areas (reviewed in [9]), which immunohisto-
chemically stain strongly for S-100 protein [10].
The presence of multiple schwannomas in a single pa-
tient suggests possible association with neurofibroma-
tosis type 2 (NF2) or schwannomatosis. The hallmark of
NF2 is bilateral vestibular schwannomas resulting from
NF2 tumor suppressor gene germline mutation. Schwan-
nomatosis is characterized by multiple pathologically
proven schwannomas without vestibular tumors diagnos-
tic of NF2. Although most schwannomatosis cases are
sporadic, instances of autosomal dominant transmission
with incomplete penetrance have also been reported [11],
though linkage analysis has now excluded the NF2 locus,
suggesting schwannomatosis is a distinct entity [12-15].
Accurate characterization of schwannomatosis is im-
portant as it is a prognostic factor that helps guide treat-
ment. Here we present two cases, a 59-year old man
with clinically recurrent orbital schwannomatosis, mani-
festing as multiple independent schwannomas that likely
arose de novo, contrasting with a 5-year old girl with a
case of a recurrent isolated orbital schwannomas whod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tumor within 1 month of each surgery.
Case presentation
Case 1
A 59-year old man with a past medical and surgical his-
tory significant for diabetes mellitus, hypertension, sleep
apnea, and thyroid lobectomy for goiter first presented
in September 2004 complaining of intermittent vertical
diplopia. On examination, there was a palpable mass of
the superomedial orbit. An MRI demonstrated this to be
a dense, well-circumscribed lesion, and a 27 x 10 x
10 mm mass was completely excised via a left anterior
orbitotomy. Histopathologic exam revealed a schwan-
noma with intense positivity for S-100 protein
(Figure 1A). Post-operatively, the diplopia improved but
did not resolve, and he developed upper lid ptosis that
was surgically repaired via levator plication in 2005.
The patient returned to our clinic in 2010, reporting
increased diplopia, left-sided proptosis, left forehead
hypesthesia and left upper lid droop. An MRI of the
orbits revealed a large left superior orbital mass with
patchy enhancement on T2 imaging (Figure 1B). The
mass was noted to be located more laterally than the
2005 schwannoma location. He underwent left anterior
orbitotomy with complete resection of a 27 x 25 x
15 mm orbital mass (Figure 1C, D), with partialFigure 1 Case 1. Orbital schwannomatosis. A: Histopathology of first tu
schwannoma. Original magnification 200x. B: Magnetic resonance imaging
superior orbital lesions (arrows) with patchy enhancement on T1 (B) and T
pathology of excised mass, with window in capsule showing contents. E: H
Original magnificantion 100x and 400x (inset).sacrifice of superior oculomotor nerve fibers. In
addition, a second 8 x 5 x 2 mm mass, distinct from the
primary mass and located superiorly on the edge of the
orbital rim was observed intraoperatively and excised
completely. This second mass was clearly spatially dis-
tinct from the larger tumor (Figure 1B-B’, arrows).
Histopathology revealed both masses to be schwanno-
mas with similar histopathologic patterns, including
clusters of lipidized xanthoma cells (Figure 1E). Post-op-
eratively, the proptosis resolved, but the patient contin-
ued to complain of diplopia and worsened ptosis, and
underwent successful strabismus and frontalis sling sur-
geries. A complete neurologic and medical evaluation
failed to reveal any additional clinical features that would
suggest neurofibromatosis. The findings support the hy-
pothesis that each schwannoma arose de novo, repre-
senting orbital schwannomatosis.
Case 2
The second patient was a 5-year old girl who presented
with a left medial canthal mass increasing in size over
the previous 1 year. At that time the patient was under-
going chemotherapy for acute lymphocytic leukemia
(ALL). She underwent excision of this mass at an outside
facility with histopathology suggesting schwannoma. The
mass recurred within 1 month of excision and the pa-
tient underwent a second excision 4 months after themor excision (H&E and IHC) revealing S-100 positivity (inset), indicating
of the recurrent tumor demonstrating two distinct well-circumscribed
2 (B’) imaging. C: Intraoperative photo of excised mass. D: Gross
istopathology of recurrent lesion (H&E) revealing schwannoma.
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noma. Within 1 month of excision, the mass again began
to enlarge and by 1 year had returned to its original size.
At this point the patient was referred to our clinic for
further evaluation and treatment.
At our initial evaluation, the patient’s ALL was in re-
mission. She was otherwise healthy and developmentally
normal without evidence of other abnormal masses or
signs of neurofibromatosis. On ophthalmologic examin-
ation, the patient’s visual acuity was 20/20 bilaterally
with normal pupil examination and extraocular motility.
External examination revealed a mobile 9 x 10 mm left
medial canthal mass resting on the underlying orbital
bone with an overlying scar. The remainder of her
examination was unremarkable. An MRI scan revealed a
well-circumscribed, contrast enhancing mass without
posterior extension and possible bone involvement. The
pathology slides from the specimens obtained during the
two previous excisions were reviewed, revealing plexi-
form cellular schwannoma.
The patient underwent left medial anterior orbitotomy
with complete excision of the 15 x 11 x 5 mm canthal
mass with uninvolved margins (Figure 2A). Histopath-
ology again illustrated a plexiform arrangement with the
lesion divided into bundles, each of which surrounded a
remnant nerve, with characteristic nodularity, fascicles
of palisading spindle cells with storiform appearance,
and lack of necrosis or myxoid changes (Figure 2B).
Immunohistochemical stains confirmed the morphologic
diagnosis with diffuse S-100 protein positivity. Given the
risks of radiation in a child and the lack of aggressive
morphology, this treatment option was not pursued. At
3 and 6-month follow-up evaluations, there were no
signs of recurrence. Further workup to assess for the
possibility of neurofibromatosis was negative.
Conclusions
Our cases demonstrate different mechanisms for
schwannoma recurrence: residual tumor in the case of
the 5-year old girl (leading to rapid recurrence), andFigure 2 Case 2. Plexiform cellular schwannoma. A: Gross pathology of
revealing schwannoma. Original magnification 50x and 200x (inset).likely de novo recurrence in the case of the 59-year old
man (leading to late recurrence).
Although orbital schwannomatosis is a rare entity, our
59-year old male patient (case 1) fits previously proposed
diagnostic criteria, with multiple independent histologi-
cally confirmed schwannomas in his left orbit and no
evidence of NF2 [16,17]. Although the schwannomas
had similar histopathological patterns and were in prox-
imity to one another, they were in spatially distinct both
surgically and radiologically (Figure 1 B/B’). Schwanno-
matosis can be heritable or sporadic, manifests as a pro-
pensity to develop schwannomas in the absence of the
usual signs of NF2, and can be associated with any nerve
in the orbit [6,18,19]. It is notable that the new schwan-
nomas in this patient occurred years, rather than
months, after the initial excision. However, it remains
theoretically possible that the recurrent tumors in case 1
were seeded at the time of the original tumor resection
in 2005.
Interestingly, at the time our 5-year old girl (case 2)
was originally diagnosed with orbital schwannoma, she
was undergoing chemotherapy treatment for ALL.
There is one case in the Japanese literature of a pa-
tient diagnosed with a thoracic schwannoma while in
remission from acute lymphoblastic leukemia, although
with only two known cases, a causal relationship be-
tween ALL and schwannomas cannot be concluded
[20]. Patients with NF1 are predisposed to juvenile
myelomonocytic leukemia [16], but our patient had no
other signs of NF1 despite a complete evaluation. Case
2 is somewhat unusual in that the isolated orbital
schwannoma recurred twice, each within 1 month of
excision. Despite the plexiform features, and although
the previous excisions were most likely incomplete, it
is still rare that the tumor recurred so rapidly. Malig-
nant peripheral nerve sheath tumors are much more
aggressive lesions and can quickly recur even with
complete excision [21], but histopathology of the final
specimen showed only benign features, and there were
no further recurrences.excised mass measuring 15 mm by 12 mm. B: Histopathology (H&E)
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schwannomas, radiation therapy is an alternative treat-
ment is some cases. However, even with vestibular
schwannomas, the efficacy of radiation therapy is un-
clear [22]. Furthermore, radiation exposure carries sig-
nificant risk for secondary malignancies [23], and hence
the use of radiation therapy to treat benign conditions
should be approached with caution.
In summary, we report 2 cases of recurrent orbital
schwannomas, demonstrating the challenge of treating
this tumor. In both cases, the patients should be carefully
monitored for further recurrences. In cases of schwanno-
matosis, patients should be advised that the goal of
therapy may be mostly palliative, and that close moni-
toring would be required in order to facilitate early
intervention of further recurrences, before the tumor
size becomes problematic. In the case of plexiform
schwannomas, the patient and family should be advised
of the risk of early recurrence.
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